Sorrento and Mount Sinai Health System Enter Into Exclusive License Agreement for Development of Potent Antibody Combinations Aimed at Neutralizing SARS-CoV-2 and the Emerging United Kingdom and South Africa Variants of COVID-19
Sorrento is moving forward with the research and development of COVISHIELD antibody combinations with potentially potent neutralizing activities against early...